Etiopatogenia da ELA: causa única ou várias causas?

Autores

  • Helga Cristina Almeida da Silva Médica neurologista, Doutora, Professora afiliada e orientadora da Pós-graduação da UNIFESP.

DOI:

https://doi.org/10.34024/rnc.2006.v14.8768

Palavras-chave:

Suplemento

Resumo

.

Downloads

Não há dados estatísticos.

Métricas

Carregando Métricas ...

Referências

Brown RH. Amyotrophic lateral sclerosis. Arch Neurol 1997; 54:1246-1250.

Cluskey S, Ramsden DB. Mechanisms of neurodegeneration in amyotrophic lateral sclerosis. J Clin Pathol: Mol Pathol 2001; 54:386-392.

Fischer LR, Culver DG, Tennant P, Davis AA, Wang M, Castellano-Sanchez A, et al. Amyotrophic lateral sclerosis is a distal axonopathy: evidence in mice and man. Exp Neurol 2004; 185(2):232-40.

Hand CK, Rouleau GA. Familial amyotrophic lateral sclerosis. Muscle Nerve 2002; 25:135-159.5.Hosler BA, Brown RH Jr. Copper/zinc superoxide dismutase mutations and free radical damage in amyotrophic lateral sclerosis. Adv Neurol 1995; 68:41-46.

Ihara Y, Mori A, Hayabara T, Kawai M, Namba R, Nobokuni K, et al. Superoxide dismutase and free radicals in sporadic amyotrophic lateral sclerosis: relationship to clinical data. J Neurol Sci 1995; 134:51-56.

Majoor-Krakauer D, Willems PJ, Hofman A. Genetic epidemiology of amyotrophic lateral sclerosis. Clin Genet. 2003; 63(2):83-101.

Marx J. Mutant enzime provides new insights into the cause of ALS. Science 1996; 21:446-447. 9.Munsat TL, Andres MS, Finison L, Conlon MPH, Thibodeau PTA. The natural history of motoneuron loss in amyotropihc lateral sclerosis. Neurology 1988; 38:409-413.

Neilson S, Robison I, Rose FC. Mortality from motor neuron disease in Japan, 1950-1990: association with radioactive fallout from atmospheric weapons testing. J Neurol Sci 1995; 134:61-66.

Olanow CW, Arendash GW. Metal and free radicals in neurodegeneration. Current Opinion in Neurology 1994; 7:548-558.

Rouleau GA, Clark AW, Rooke K, Pramatarowa A, Krizus A, Suchowersky O, et al. SOD1 mutation is associated with accumulation of neurofilaments in amyotrophic lateral esclerosis. Ann Neurol 1996; 39:128-131.

Rowland LP. Amyotrophic lateral sclerosis: theories and therapies. Ann Neurol 1994;35:129-130.

Rowland LP. Amyotrophic lateral sclerosis. Cur Opin Neurol 1994; 7:310-315.

Serratrice GT, Munsat TL. Pathogenesis and therapy of amyotrophic lateral sclerosis. Advances in Neurology (vol 68). New York: Lippincott-Raven, 1995, p.1-290.

Silva HCA. Aplicabilidade da Biologia molecular: Doenças neurológicas. Biologia Molecular: guia prático e didático. Eça LPM (Org.). Rio de Janeiro: Revinter, 2004, p.216-222.

Swash M, Schwartz MS. What do we really know about amyotrophic lateral sclerosis? J Neurol Sci 1992; 113:4-16.

Urushitani M, Kurisu J, Tateno M, Hatakeyama S, Nakayama K, Kato S, Takahashi R CHIP promotes proteasomal degradation of familial ALS-linked mutant SOD1 by ubiquitinating Hsp/Hsc70. J Neurochem. 2004; 90(1):231-244.

Wiedau-Pazos M, Goto JJ, Rabizadeh S, Gralla EB, Roe JA, Lee MK, et al. Altered reactivity of superoxide dismutase in familial amyotrophic laterla sclerosis. Science 1996, 271:515-518.

Williams BD, Windebank AJ. Motor neuron disease. In Dick PJ and Thomas PK (eds.). Peripheral Neuropathy. Philadelphia: WB Saunders Company, Third edition, 1993, p.1028-1050.

Downloads

Publicado

2006-10-31

Como Citar

Silva, H. C. A. da. (2006). Etiopatogenia da ELA: causa única ou várias causas?. Revista Neurociências, 14, 35–42. https://doi.org/10.34024/rnc.2006.v14.8768
Recebido: 2019-02-28
Publicado: 2006-10-31

Artigos mais lidos pelo mesmo(s) autor(es)